CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $88,139 | -34.9% | 151,000 | 0.0% | 0.02% | -31.4% |
| Q1 2024 | $135,492 | +28.4% | 151,000 | -2.0% | 0.04% | +66.7% |
| Q3 2023 | $105,487 | -42.1% | 154,130 | -1.1% | 0.02% | -56.2% |
| Q1 2023 | $182,345 | +48.1% | 155,850 | 0.0% | 0.05% | +45.5% |
| Q4 2022 | $123,122 | -35.2% | 155,850 | -0.6% | 0.03% | -37.7% |
| Q3 2022 | $190,000 | +31.9% | 156,850 | 0.0% | 0.05% | +51.4% |
| Q2 2022 | $144,000 | -48.8% | 156,850 | 0.0% | 0.04% | -39.7% |
| Q1 2022 | $281,000 | -11.6% | 156,850 | 0.0% | 0.06% | -18.3% |
| Q3 2021 | $318,000 | -41.8% | 156,850 | 0.0% | 0.07% | -45.4% |
| Q2 2021 | $546,000 | – | 156,850 | +46.8% | 0.13% | – |
| Q1 2021 | $0 | -100.0% | 106,850 | +0.9% | 0.00% | -100.0% |
| Q4 2020 | $107,000 | – | 105,850 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 61,613 | $48,674 | 0.00% |
| Kestra Advisory Services, LLC | 93,717 | $74,036 | 0.00% |